Ledger.Open graph →
SEC Form D · filed July 26, 2021

Manistee Therapeutics, Inc

Offering
$9.5M
Sold
$9.5M
Exemption
Rule 506(b)
Industry
Other
Location
CONCORD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Stephen L. Bruso · Concord, MADirectorBradford J. Shingleton, M.D · Concord, MAExec · DirectorRobert L. Bratzler, Ph.D · Concord, MAExec · DirectorBradford J. Shingleton, M.D · Concord, MAExec · DirectorRobert L. Bratzler, Ph.D · Concord, MAExec · DirectorStephen L. Bruso · Concord, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗